1700001C02Rik Activators
1700001C02Rik Activators reflect a diverse array of chemical compounds that each, through distinct biochemical pathways, enhance the functional activity of 1700001C02Rik. Compounds such as Forskolin and 8-Bromo-cAMP, by increasing intracellular levels of cAMP, activate PKA, which may phosphorylate substrates that interact with or modulate 1700001C02Rik, enhancing its activity. Similarly, Epigallocatechin gallate, a kinase inhibitor, and LY294002, a PI3K inhibitor, might act to lift inhibitory controls on pathways that regulate 1700001C02Rik function, allowing for its increased activity. Sildenafil, through its inhibition of PDE5, increases cGMP levels, which could also contribute to the activation of 1700001C02Rik by engaging cGMP-dependent kinases or signaling mechanisms. Anisomycin, by activating JNK and p38 MAPK pathways, may indirectly increase the activity of 1700001C02Rik if it interacts with stress-response signaling cascades.
In addition to these mechanisms, the modulation of intracellular calcium levels by compounds like Ionomycin and BAPTA-AM suggests an indirect approach to enhance 1700001C02Rik activity, given its potential involvement in calcium-dependent signaling processes. Phorbol 12-myristate 13-acetate (PMA), as a PKC activator, may also escalate the activity of 1700001C02Rik by promoting PKC-dependent signaling pathways. Meanwhile, PD98059 and SB203580 disrupt MEK and p38 MAPK signaling, respectively, which might result in the activation of compensatory pathways or proteins that could enhance 1700001C02Rik function. Okadaic Acid's inhibition of protein phosphatases 1 and 2A suggests that an increase in the phosphorylated state of cellular proteins could include 1700001C02Rik, potentially boosting its activity. Collectively, these chemical activators, by targeting different cellular signaling pathways, facilitate the enhancement of 1700001C02Rik's activity without necessitating its direct activation or upregulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate acts as a kinase inhibitor, potentially reducing competitive signaling and allowing for the activation of pathways in which 1700001C02Rik is involved. This could result in the enhanced activity of 1700001C02Rik through the alleviation of inhibitory kinase activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent proteins and pathways. This rise in calcium may indirectly enhance the activity of 1700001C02Rik if it is involved in calcium-dependent signaling or functional regulation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC), which is involved in regulating a variety of cellular responses. Activation of PKC could enhance the activity of 1700001C02Rik if it is part of or regulated by PKC-dependent signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter PI3K/Akt signaling. By inhibiting PI3K, LY294002 may reduce negative feedback loops and indirectly increase the activity of proteins that are activated by other pathways potentially involving 1700001C02Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that can interfere with the MAPK/ERK pathway. Inhibition of MEK may lead to compensatory activation in alternative pathways, potentially enhancing the activity of 1700001C02Rik if it plays a role in these alternative signaling processes. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator that can modulate intracellular calcium levels. By altering calcium signaling, BAPTA-AM may indirectly activate signaling cascades or proteins that interact with or enhance the activation of 1700001C02Rik. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), leading to increased phosphorylation of cellular proteins. This inhibition may enhance the phosphorylation state and thus the activity of 1700001C02Rik if it is regulated by these phosphatases. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can also activate JNK and p38 MAPK pathways. By activating these stress-activated pathways, anisomycin could enhance the functional activity of 1700001C02Rik if it plays a role in the cellular response to stress. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that can activate cAMP-dependent pathways. By mimicking cAMP, this compound can activate PKA and potentially enhance the activity of 1700001C02Rik through cAMP-responsive elements or pathways. | ||||||